Congress Park Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,310
Closed -$792K 142
2022
Q3
$792K Sell
4,310
-3,554
-45% -$708K 0.46% 49
2022
Q2
$1.32M Sell
7,864
-542
-6% -$116K 0.8% 33
2022
Q1
$2.11M Sell
8,406
-2,950
-26% -$741K 1.06% 29
2021
Q4
$2.92M Sell
11,356
-335
-3% -$82K 1.44% 20
2021
Q3
$2.84M Sell
11,691
-500
-4% -$122K 1.45% 19
2021
Q2
$2.52M Sell
12,191
-655
-5% -$133K 1.26% 22
2021
Q1
$2.42M Buy
12,846
+30
+0.2% +$5.29K 1.35% 17
2020
Q4
$2.11M Buy
12,816
+4,274
+50% +$625K 1.25% 21
2020
Q3
$1.06M Sell
8,542
-1,544
-15% -$191K 0.66% 39
2020
Q2
$979K Buy
10,086
+6,336
+169% +$659K 0.75% 37
2020
Q1
$337K Buy
+3,750
New +$486K 0.3% 59

Other funds holding HCA

Congress Park Capital's HCA Position: Q4 2022 in Review

Congress Park Capital sold out of HCA Healthcare (HCA) in Q4 2022, closing a stake of 4,310 shares — an estimated $792K sold.

Congress Park Capital first reported a position in HCA in Q1 2020 and held it in 11 quarters. The position peaked at $2.92M in Q4 2021. 961 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • Congress Park Capital reported no remaining HCA Healthcare position as of Q4 2022 after selling out during the quarter.
  • Congress Park Capital sold 4,310 HCA Healthcare shares in Q4 2022, an estimated $792K.
  • Congress Park Capital first reported a position in HCA Healthcare in Q1 2020 and held it in 11 quarters.
  • Congress Park Capital's HCA Healthcare position peaked at $2.92M in Q4 2021.
  • 961 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on Congress Park Capital's 13F filing for Q4 2022, filed 30 Jan 2023.